Etoposide 100 mg/5 mL Injection (Bulk)

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

etoposide, Quantity: 20 mg/mL

Disponible des:

Pfizer (Perth) Pty Ltd

Designació comuna internacional (DCI):

Etoposide

formulario farmacéutico:

Injection, intravenous infusion

Composición:

Excipient Ingredients: macrogol 300; citric acid; polysorbate 80; ethanol absolute

Vía de administración:

Intravenous

Unidades en paquete:

5 mL x 1, 5 mL x 10

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

For the treatment of small cell lung cancer and testicular tumours, either as a single agent or in combination with other anticancer agents.

Resumen del producto:

Visual Identification: Clear, colourless to straw coloured solution, free from visible defects; Container Type: Vial; Container Material: PP; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2016-11-11